Effective treatment strategies for paediatric community-acquired pneumonia

Antibiotic treatment strategies for community-acquired pneumonia in adults.

BACKGROUND The choice of empirical antibiotic treatment for patients with clinically suspected community-acquired pneumonia (CAP) who are admitted to non-intensive care unit (ICU) hospital wards is complicated by the limited availability of evidence. We compared strategies of empirical treatment (allowing deviations for medical reasons) with beta-lactam monotherapy, beta-lactam-macrolide combin...

Risk factors of paediatric community-acquired pneumonia.

The article by TEEPE et al. [1] recently published in the European Respiratory Journal is an interesting paper on the risk factors of community-acquired pneumonia (CAP) in children and adults in a primary-care setting. The study population consisted of 156 young adults and 107 children (aged ,15 yrs) suffering from CAP, and three controls were selected for each case from the same age group. The...

Treatment of community-acquired pneumonia.

Changing clinical practice: management of paediatric community-acquired pneumonia

RATIONALE AND AIM To compare clinical features and management of paediatric community-acquired pneumonia (PCAP) following the publication of UK pneumonia guidelines in 2002 with data from a similar survey at the same hospitals in 2001-2002 (pre-guidelines). METHODS A prospective survey of 11 hospitals in Northern England was undertaken during 2008-2009. Clinical and laboratory data were recor...

Pneumococcal Aetiology and Serotype Distribution in Paediatric Community-Acquired Pneumonia

Community-acquired pneumonia (CAP) is a major cause of morbidity in children. This study estimated the proportion of children with pneumococcal CAP among children hospitalised with CAP in Belgium and describes the causative serotype distribution after implementation of the 7-valent pneumococcal conjugate vaccine. Children 0-14 years hospitalised with X-ray-confirmed CAP were prospectively enrol...